Edition:
United Kingdom

People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

6,376JPY
19 Apr 2019
Change (% chg)

¥11 (+0.17%)
Prev Close
¥6,365
Open
¥6,438
Day's High
¥6,462
Day's Low
¥6,367
Volume
530,700
Avg. Vol
1,090,833
52-wk High
¥11,490
52-wk Low
¥6,040

Kobayashi, Hiroyuki 

Mr. Hiroyuki Kobayashi has been serving as Executive Officer, Chief Medical Officer of Japan & Asia and Chief Director of Medical in Eisai Co., Ltd. since June 2017. He joined the Company in January 2016. His previous titles include Director of Neurology Medical Department and Director of Oncology Medical in the Company. He used to work for Otsuka Pharmaceutical Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --